2025 annual financial data
Galmed Pharmaceuticals 2025 Operating margin
Galmed Pharmaceuticals 2025 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -8,510,000 USD and net income was -10,309,000 USD.
Operating cash flow was -6,315,000 USD.
Get free Galmed Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -8,510,000 USD
- Net income
- -10,309,000 USD
- Operating cash flow
- -6,315,000 USD